Long-term retention of patients in antiretroviral therapy (ART) programmes is essential for achieving optimal adherence and successful treatment of HIV. With funding from the Canadian International Development Agency (CIDA), Cell-Life in collaboration with Maternal Adolescent and Child Health (MatCH) designed a multi-site, open-label, randomised controlled trial to evaluate the use of SMSs to improve retention and decrease treatment interruptions amongst patients initiating ART.Visit Website
Connect with us
© 2013 Cell-Life. All Rights Reserved.
Tel: +27(0)21 462 6481
Or click here